<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37056914</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-4593</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Brain disorders (Amsterdam, Netherlands)</Title><ISOAbbreviation>Brain Disord</ISOAbbreviation></Journal><ArticleTitle>COVID-19 delirium and encephalopathy: Pathophysiology assumed in the first 3 years of the ongoing pandemic.</ArticleTitle><Pagination><StartPage>100074</StartPage><MedlinePgn>100074</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dscb.2023.100074</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The coronavirus disease (COVID-19) continues to spread worldwide. It has a high rate of delirium, even in young patients without comorbidities. Infected patients required isolation because of the high infectivity and virulence of COVID-19. The high prevalence of delirium in COVID-19 primarily results from encephalopathy and neuroinflammation caused by acute respiratory distress syndrome (ARDS)-associated cytokine storm. Acute respiratory distress syndrome has been linked to delirium and psychotic symptoms in the subacute phase (4 to 12 weeks), termed post-acute COVID-19 syndrome (PACS), and to brain fog, cognitive dysfunction, and fatigue, termed "long COVID," which persists beyond 12 weeks. However, no review article that mentions "COVID-19 delirium" have never been reported.</AbstractText><AbstractText Label="BASIC PROCEDURES" NlmCategory="UNASSIGNED">This narrative review summarizes data on delirium associated with acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and related neurological symptoms of persistent post-infection illness (PACS or long COVID) after persistence of cognitive dysfunction. Thus, we describe the pathophysiological hypothesis of COVID-19 delirium and its continuation as long COVID. This review also describes the treatment of delirium complicated by COVID-19 pneumonia.</AbstractText><AbstractText Label="MAIN FINDINGS" NlmCategory="UNASSIGNED">SARS-CoV-2 infection is associated with encephalopathy and delirium. An association between COVID-19 infection and Alzheimer's disease has been suggested, and studies are being conducted from multiple facets including genetics, cytology, and postmortem study.</AbstractText><AbstractText Label="PRINCIPAL CONCLUSIONS" NlmCategory="UNASSIGNED">This review suggests that COVID-19 has important short and long-term neuropsychiatric effects. Several hypotheses have been proposed that highlight potential neurobiological mechanisms as causal factors, including neuronal-inflammatory pathways by cytokine storm and cellular senescence, and chronic inflammation.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Otani</LastName><ForeName>Kyohei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Kobe City Medical Center General Hospital, 2-1-1, Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Kakogawa Central City Hospital, 439, Kakogawa-cho honmachi, Kakogawa City, Hyogo, 675-8611, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukushima</LastName><ForeName>Haruko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Kobe City Medical Center General Hospital, 2-1-1, Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuishi</LastName><ForeName>Kunitaka</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Kobe City Medical Center General Hospital, 2-1-1, Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Brain Disord</MedlineTA><NlmUniqueID>101775252</NlmUniqueID><ISSNLinking>2666-4593</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Delirium</Keyword><Keyword MajorTopicYN="N">Encephalopathy</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">microglia</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>2</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37056914</ArticleId><ArticleId IdType="pmc">PMC10076074</ArticleId><ArticleId IdType="doi">10.1016/j.dscb.2023.100074</ArticleId><ArticleId IdType="pii">S2666-4593(23)00011-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Helms J., Kremer S., Merdji H., Schenck M., Severac F., Clere-Jehl R., Studer A., Radosavljevic M., Kummerlen C., Monnier A., Boulay C., Fafi-Kremer S., Castelain V., Ohana M., Anheim M., Schneider F., Meziani F. Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit. Care. 2020;24:491. doi: 10.1186/s13054-020-03200-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03200-1</ArticleId><ArticleId IdType="pmc">PMC7414289</ArticleId><ArticleId IdType="pubmed">32771053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotfis K., Roberson S.W., Wilson J.E., Dabrowski W., Pun B.T., Ely E.W. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit. Care. 2020;24:176. doi: 10.1186/s13054-020-02882-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02882-x</ArticleId><ArticleId IdType="pmc">PMC7186945</ArticleId><ArticleId IdType="pubmed">32345343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotfis K., Roberson S.W., Wilson J., Pun B., Ely E.W., Je&#x17c;owska I., Jezierska M., Dabrowski W. COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic? Anaesthesiol. Intensive Ther. 2020;52:132&#x2013;138. doi: 10.5114/ait.2020.95164.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2020.95164</ArticleId><ArticleId IdType="pmc">PMC7667988</ArticleId><ArticleId IdType="pubmed">32419438</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael B.D., Walton D., Westenberg E., Garc&#xed;a-Azor&#xed;n D., Singh B., Tamborska A.A., Netravathi M., Chomba M., Wood G.K., Easton A., Siddiqi O.K., Jackson T.A., Pollak T.A., Nicholson T.R., Nair S., Breen G., Prasad K., Thakur K.T., Chou S.H., Schmutzhard E., Frontera J.A., Helbok R., Padovani A., Menon D.K., Solomon T., Winkler A.S. Global COVID-19 neuro research coalition. consensus clinical guidance for diagnosis and management of adult COVID-19 encephalopathy patients. J. Neuropsychiatry Clin. Neurosci. 2023;35:12&#x2013;27. doi: 10.1176/appi.neuropsych.22010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.22010002</ArticleId><ArticleId IdType="pubmed">35872617</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun B.T., Badenes R., Calle G.H.L., Orun O.M., Chen W., Raman R., Simpson B.-G.K., Wilson-Linville S., Olmedillo B.H., de la Cueva A.V., van der Jagt M., Casado R.N., Sanz P.L., Orhun G., G&#xf3;mez C.F., V&#xe1;zquez K.N., Otero P.P., Taccone F.S., Curto E.G., Caricato A., Woien H., Lacave G., O'Neal H.R., Peterson S.J., Brummel N.E., Girard T.D., Ely E.W., Pandharipande P.P., C.-19 I.C.I.S. Group. Creteur J., Bogossian E.G., Peluso L., Gonz&#xe1;lez-Seguel F., Hidalgo-Calibin V., Carre&#xf1;o-Montenegro P., Rojas V., Tobar E., Ram&#xed;rez-Palma A., Herrera-Davis K., Ferr&#xe9; A., Legriel S., Godet T., Fraisse U., Gon&#xe7;alves B., Mazeraud A., Tzimou M., Rasulo F., Beretta S., Marchesi M., Robba C., Battaglini D., Pelosi P., Mazzeo A.T., Noto A., Servillo G., Marra A., Cutuli S.L., Pintaudi G., Stival E., Tanzarella E.S., Roman-Pognuz E., Massaro C.M.C., Elhadi M., Smit L., Olasveengen T., Pereira I.J., Teixeira C.M., Santos A., Valente M., Granja C., Pereia R., Silva J., Furquet B., Sim&#xf3;n M.G., Torres D.A.G., Monle&#xf3;n B., Morcillo E., Romero N., Serrano A., S&#xe1;nchez S.T., Caballero F.L.P., Luna I.P., G&#xf3;mez I.B., Vargas M.C., P&#xe9;rez J.M., G&#xf3;mez G.C., Latorre R.M., Guti&#xe9;rrez S.M., Barrera I.P.B., Palacios C.D., G&#xf3;ngora B.G., Romero L.L., Galarza L., Catal&#xe1;n-Monz&#xf3;n I., Rodriguez-Mart&#xed;nez E., Gubianas C.M., Bell&#xe8;s A., Delgado M.E.R., Caballero J., Morales D., Pujol A., Rubio J., Torres E.&#xc1;., Revuelta E.C., de la I., Gil C., Tom&#xe1;s B.F., Rodr&#xed;guez B.G., Serrano M.G., Andreu P.L., Lucendo A.P., Palomares E.A., Gonz&#xe1;lez E.G., Delgado M.C.M., Cabo C.M.D., Aznar P.T., Calvo C.A., Garutti I., Higuero F., Mart&#xed;nez-Gascue&#xf1;a D., Maseda E., Insausti I., Feijoo A.M., Suarez-de-la-Rica A., Barbudo B.D.M., Blanco-Traba Y.G., Santamarina M.C.G., Mill&#xe1;n A.G., Damas S.L., Lagunas D.P., Garc&#xed;a I.R., Perea A.R., Guerrero &#xc1;.O., Cubillo M.J.M., Mu&#xf1;oz D.D., Ramal S.G.de C.i, Sunyer X.A., de las M., Moreno N.N., Manrique R.M.P., del E., Molina C., Quintana M.E.M., Fernandez-Gonzalo S., Fern&#xe1;ndez G.G., Navarra-Ventura G., Serra A.B., Fuster C., Galv&#xe1;n O.P., Gil-Castillejos D., Gonz&#xe1;lez M.D., Gallego F.J.M., Borrachero I.P., Villamizar P.R., Prieto J.R., Carretero M.J.S., S&#xe1;nchez S.G., Molina F.B., P&#xe9;rez M.L.G., Castello-Mora P., Puig J., Sanchis-Martin M.R., Sanchis-Veryser C.A., Vicente-Fern&#xe1;ndez M.P., Zaragoza R., Lizama L., Torres I., &#xc1;lvarez C., Ram&#xed;rez P., Cerezuela M.M., Montero M.J., Cantos J.G., Valls P., Cortajarena N.A., Domelo P.G., Cubillo L.G., Mart&#xed;nez M.M., Francisco I.P., Hern&#xe1;ndez Y.P., Rodero A.Q., Nu&#xf1;ez C.R., Siegemund M., Estermann A., Zellweger N., Saida I.B., Boussarsar M., Esen F., &#xd6;zcan P.E., Berkey C., Harb C., Tandy M.H., Morgan E., Shephard K., Hyzy R.C., Kenes M., Nelson K., Hosse R.E., Vance K.M., Austin C.A., Lerner A., Sanders E., Balk R.A., Bennett D.A., Vogel A.R., Chowdhury L., Devulapally K., Woodham M., Cohen S., Patel N., Kuza C.M., Sing M., Roberson S., Drumright K., Sehgal S., LaHue S.C., Douglas V.C., Sarwal A. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir. Med. 2021;9:239&#x2013;250. doi: 10.1016/s2213-2600(20)30552-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(20)30552-x</ArticleId><ArticleId IdType="pmc">PMC7832119</ArticleId><ArticleId IdType="pubmed">33428871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy M., Helfand B.K.I., Gou R.Y., Gartaganis S.L., Webb M., Moccia J.M., Bruursema S.N., Dokic B., McCulloch B., Ring H., Margolin J.D., Zhang E., Anderson R., Babine R.L., Hshieh T., Wong A.H., Taylor R.A., Davenport K., Teresi B., Fong T.G., Inouye S.K. Delirium in older patients with COVID-19 presenting to the emergency department. JAMA Netw. Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.29540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.29540</ArticleId><ArticleId IdType="pmc">PMC7677760</ArticleId><ArticleId IdType="pubmed">33211114</ArticleId></ArticleIdList></Reference><Reference><Citation>Callea A., Conti G., Fossati B., Carassale L., Zagaria M., Caporotundo S., Ziglioli E., Brunetti V., Marca G.D., Rollo E. Delirium in hospitalized patients with COVID-19 pneumonia: a prospective, cross-sectional, cohort study. Intern. Emerg. Med. 2022;17:1445&#x2013;1452. doi: 10.1007/s11739-022-02934-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-02934-w</ArticleId><ArticleId IdType="pmc">PMC8793095</ArticleId><ArticleId IdType="pubmed">35084645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins M., Sockalingam S., Bonato S., Rajaratnam T., Ravindran M., Gosse P., Sheehan K.A. A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19. J. Psychosom. Res. 2021;141 doi: 10.1016/j.jpsychores.2020.110350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2020.110350</ArticleId><ArticleId IdType="pmc">PMC7762623</ArticleId><ArticleId IdType="pubmed">33401078</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcez F.B., Aliberti M.J.R., Poco P.C.E., Hiratsuka M., Takahashi S.de F., Coelho V.A., Salotto D.B., Moreira M.L.V., Jacob-Filho W., Avelino-Silva T.J. Delirium and adverse outcomes in hospitalized patients with COVID-19. J. Am. Geriatr. Soc. 2020;68:2440&#x2013;2446. doi: 10.1111/jgs.16803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16803</ArticleId><ArticleId IdType="pmc">PMC7460960</ArticleId><ArticleId IdType="pubmed">32835425</ArticleId></ArticleIdList></Reference><Reference><Citation>Poloni T.E., Carlos A.F., Cairati M., Cutaia C., Medici V., Marelli E., Ferrari D., Galli A., Bognetti P., Davin A., Cirrincione A., Ceretti A., Cereda C., Ceroni M., Tronconi L., Vitali S., Guaita A. Prevalence and prognostic value of delirium as the initial presentation of COVID-19 in the elderly with dementia: an Italian retrospective study. Eclinicalmedicine. 2020;26 doi: 10.1016/j.eclinm.2020.100490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100490</ArticleId><ArticleId IdType="pmc">PMC7392565</ArticleId><ArticleId IdType="pubmed">32838241</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebora P., Rozzini R., Bianchetti A., Blangiardo P., Marchegiani A., Piazzoli A., Mazzeo F., Cesaroni G., Chizzoli A., Guerini F., Bonfanti P., Morandi A., Faraci B., Gentile S., Bna C., Savelli G., Citerio G., Valsecchi M.G., Mazzola P., Bellelli G., for the C.L. Team Delirium in patients with SARS-CoV-2 infection: a multicenter study. J. Am. Geriatr. Soc. 2021;69:293&#x2013;299. doi: 10.1111/jgs.16969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16969</ArticleId><ArticleId IdType="pmc">PMC7753490</ArticleId><ArticleId IdType="pubmed">33411332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou B., Guo J., Liu Y., Xiong C., Shi J., Zhou C. Prevalence, classification, risk factors and outcome impact of delirium in patients with COVID-19: a meta-analysis protocol for systematic review. BMJ Open. 2021;11 doi: 10.1136/bmjopen-2020-048323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048323</ArticleId><ArticleId IdType="pmc">PMC8671850</ArticleId><ArticleId IdType="pubmed">34903533</ArticleId></ArticleIdList></Reference><Reference><Citation>Otani K., Miura A., Miyai H., Fukushima H., Matsuishi K. Characteristics of COVID-19 delirium intervened by a psychiatric liaison team in the first 2 years of the COVID-19 pandemic in Japan. Psychiat. Clin. Neuros. 2022;76:599&#x2013;600. doi: 10.1111/pcn.13456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13456</ArticleId><ArticleId IdType="pmc">PMC9538953</ArticleId><ArticleId IdType="pubmed">35947013</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael B.D., Walton D., Westenberg E., Garc&#xed;a-Azor&#xed;n D., Singh B., Tamborska A.A., Netravathi M., Chomba M., Wood G.K., Easton A., Siddiqi O.K., Jackson T.A., Pollak T.A., Nicholson T.R., Nair S., Breen G., Prasad K., Thakur K.T., Chou S.H.-Y., Schmutzhard E., Frontera J.A., Helbok R., Padovani A., Menon D.K., Solomon T., Winkler A.S., behalf of the G.C.-19N.R Coalition, consensus clinical guidance for diagnosis and management of adult COVID-19 encephalopathy patients. J. Neuropsychiatry Clin. Neurosci. 2023;35:12&#x2013;27. doi: 10.1176/appi.neuropsych.22010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.22010002</ArticleId><ArticleId IdType="pubmed">35872617</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatakeyama J., Inoue S., Liu K., Yamakawa K., Nishida T., Ohshimo S., Hashimoto S., Kanda N., Maruyama S., Ogata Y., Kawakami D., Shimizu H., Hayakawa K., Tanaka A., Oshima T., Fuchigami T., Yawata H., Oe K., Kawauchi A., Yamagata H., Harada M., Sato Y., Nakamura T., Sugiki K., Hakozaki T., Beppu S., Anraku M., Kato N., Iwashita T., Kamijo H., Kitagawa Y., Nagashima M., Nishimaki H., Tokuda K., Nishida O., Nakamura K. Prevalence and risk factor analysis of post-intensive care syndrome in patients with COVID-19 requiring mechanical ventilation: a multicenter prospective observational study. J. Clin. Med. 2022;11:5758. doi: 10.3390/jcm11195758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195758</ArticleId><ArticleId IdType="pmc">PMC9571505</ArticleId><ArticleId IdType="pubmed">36233627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami D., Fujitani S., Morimoto T., Dote H., Takita M., Takaba A., Hino M., Nakamura M., Irie H., Adachi T., Shibata M., Kataoka J., Korenaga A., Yamashita T., Okazaki T., Okumura M., Tsunemitsu T. Prevalence of post-intensive care syndrome among Japanese intensive care unit patients: a prospective, multicenter, observational J-PICS study. Crit. Care. 2021;25:69. doi: 10.1186/s13054-021-03501-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03501-z</ArticleId><ArticleId IdType="pmc">PMC7888178</ArticleId><ArticleId IdType="pubmed">33593406</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/s2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., Harrison P.J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827. doi: 10.1016/s2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep-Uk. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Takao M., Ohira M. Neurological post-acute sequelae of SARS-CoV-2 infection. Psychiatry Clin. Neurosci. 2023;77:72&#x2013;83. doi: 10.1111/pcn.13481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13481</ArticleId><ArticleId IdType="pmc">PMC9538807</ArticleId><ArticleId IdType="pubmed">36148558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T., Kuroda N., Sone D. Neuropsychiatric aspects of long COVID: a comprehensive review. Psychiatry Clin. Neurosci. 2023;77:84&#x2013;93. doi: 10.1111/pcn.13508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13508</ArticleId><ArticleId IdType="pmc">PMC10108156</ArticleId><ArticleId IdType="pubmed">36385449</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Liu J., Lin J., Shang H. COVID-19 and risk of neurodegenerative disorders: a Mendelian randomization study. Transl. Psychiat. 2022;12:283. doi: 10.1038/s41398-022-02052-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-02052-3</ArticleId><ArticleId IdType="pmc">PMC9281279</ArticleId><ArticleId IdType="pubmed">35835752</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai S.N., Tiwari N., Singh P., Singh A.K., Mishra D., Imran Mohd., Singh S., Hooshmandi E., Vamanu E., Singh S.K., Singh M.P. Exploring the paradox of COVID-19 in neurological complications with emphasis on Parkinson's and Alzheimer's disease. Oxid. Med. Cell Longev. 2022;2022 doi: 10.1155/2022/3012778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3012778</ArticleId><ArticleId IdType="pmc">PMC9453010</ArticleId><ArticleId IdType="pubmed">36092161</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckwith N., Probert J., Rosenbaum B.L., Bains A., Angelucci V.C., Rodriguez A.E.M., London S., Zollman J.W., Ordo&#xf1;ez A.S., Kontos N., Smith F.A., Celano C.M., Beach S.R. Demographic features, physical examination findings, and medication use in hospitalized, delirious patients with and without COVID-19 infection: a retrospective study. J. Acad. Consult Psychiatry. 2023;64:35&#x2013;44. doi: 10.1016/j.jaclp.2022.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaclp.2022.07.010</ArticleId><ArticleId IdType="pmc">PMC9357932</ArticleId><ArticleId IdType="pubmed">35948255</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinola-Nadurille M., Flores-Rivera J., Rivas-Alonso V., Vargas-Ca&#xf1;as S., Fricchione G.L., Bayliss L., Martinez-Juarez I.E., Hernandez-Vanegas L.E., Martinez-Hernandez R., Bautista-Gomez P., Solis-Vivanco R., Perez-Esparza R., Bustamante-Gomez P.A., Restrepo-Martinez M., Ramirez-Bermudez J. Catatonia in patients with anti-NMDA receptor encephalitis. Psychiat. Clin. Neuros. 2019;73:574&#x2013;580. doi: 10.1111/pcn.12867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.12867</ArticleId><ArticleId IdType="pubmed">31115962</ArticleId></ArticleIdList></Reference><Reference><Citation>Slooter A.J.C., Otte W.M., Devlin J.W., Arora R.C., Bleck T.P., Claassen J., Duprey M.S., Ely E.W., Kaplan P.W., Latronico N., Morandi A., Neufeld K.J., Sharshar T., MacLullich A.M.J., Stevens R.D. Updated nomenclature of delirium and acute encephalopathy: statement of ten societies. Intensive Care Med. 2020;46:1020&#x2013;1022. doi: 10.1007/s00134-019-05907-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05907-4</ArticleId><ArticleId IdType="pmc">PMC7210231</ArticleId><ArticleId IdType="pubmed">32055887</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta E.M., Batra A., Clark J.R., Shlobin N.A., Hoffman S.C., Orban Z.S., Koralnik I.J. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann. Clin. Transl. Neur. 2020;7:2221&#x2013;2230. doi: 10.1002/acn3.51210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51210</ArticleId><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., Miao X., Li Y., Hu B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Radmanesh A., Raz E., Zan E., Derman A., Kaminetzky M. Brain imaging use and findings in COVID-19: a single academic center experience in the epicenter of disease in the United States. Am. J. Neuroradiol. 2020;41:1179&#x2013;1183. doi: 10.3174/ajnr.a6610.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.a6610</ArticleId><ArticleId IdType="pmc">PMC7357666</ArticleId><ArticleId IdType="pubmed">32467191</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas M.B. Critical medical illness and the nervous system. Continuum Lifelong Learn Neurol. 2020;26:675&#x2013;694. doi: 10.1212/con.0000000000000869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/con.0000000000000869</ArticleId><ArticleId IdType="pubmed">32487902</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson J.C., Hunt C.H., Klaas J.P., Kallmes D.F. Intracranial microhemorrhages in the setting of COVID-19: what we know so far. Neuroradiol. J. 2021;34:435&#x2013;439. doi: 10.1177/19714009211004144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/19714009211004144</ArticleId><ArticleId IdType="pmc">PMC8559007</ArticleId><ArticleId IdType="pubmed">33765876</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer P.T., Hellwig S., Blazhenets G., Hosp J.A. Molecular imaging findings on acute and long-term effects of COVID-19 on the brain: a systematic review. J. Nucl. Med. 2022;63:971&#x2013;980. doi: 10.2967/jnumed.121.263085.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.263085</ArticleId><ArticleId IdType="pmc">PMC9258567</ArticleId><ArticleId IdType="pubmed">35177424</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg R.K., Paliwal V.K., Gupta A. Encephalopathy in patients with COVID-19: a review. J. Med. Virol. 2021;93:206&#x2013;222. doi: 10.1002/jmv.26207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26207</ArticleId><ArticleId IdType="pubmed">32558956</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckman D., Bonillas A., Diniz G.B., Ott S., Roh J.W., Elizaldi S.R., Schmidt B.A., Sammak R.L., Rompay K.K.A.V., Iyer S.S., Morrison J.H. SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19. Cell Rep. 2022;41 doi: 10.1016/j.celrep.2022.111573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111573</ArticleId><ArticleId IdType="pmc">PMC9554328</ArticleId><ArticleId IdType="pubmed">36288725</ArticleId></ArticleIdList></Reference><Reference><Citation>Casez O., Willaume G., Grand S., Nemoz B., Lupo J., Kahane P., Brion J.-.P. Teaching NeuroImages: sARS-CoV-2&#x2013;related encephalitis: MRI pattern of olfactory tract involvement. Neurology. 2021;96:e645&#x2013;e646. doi: 10.1212/wnl.0000000000011150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000011150</ArticleId><ArticleId IdType="pubmed">33154083</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMarino C., Lee M.-.H., Cowen M., Steiner J.P., Inati S., Shah A.H., Zaghloul K.A., Nath A. Detection of SARS-CoV-2 nucleocapsid and microvascular disease in the brain: a case report. Neurology. 2022 doi: 10.1212/wnl.0000000000201682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000201682</ArticleId><ArticleId IdType="pmc">PMC10065204</ArticleId><ArticleId IdType="pubmed">36526429</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryce C., Grimes Z., Pujadas E., Ahuja S., Beasley M.B., Albrecht R., Hernandez T., Stock A., Zhao Z., AlRasheed M.R., Chen J., Li L., Wang D., Corben A., Haines G.K., Westra W.H., Umphlett M., Gordon R.E., Reidy J., Petersen B., Salem F., Fiel M.I., Jamal S.M.E., Tsankova N.M., Houldsworth J., Mussa Z., Veremis B., Sordillo E., Gitman M.R., Nowak M., Brody R., Harpaz N., Merad M., Gnjatic S., Liu W.-.C., Schotsaert M., Miorin L., Gomez T.A.A., Ramos-Lopez I., Garcia-Sastre A., Donnelly R., Seigler P., Keys C., Cameron J., Moultrie I., Washington K.-.L., Treatman J., Sebra R., Jhang J., Firpo A., Lednicky J., Paniz-Mondolfi A., Cordon-Cardo C., Fowkes M.E. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Modern Pathol. 2021;34:1456&#x2013;1467. doi: 10.1038/s41379-021-00793-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-021-00793-y</ArticleId><ArticleId IdType="pmc">PMC8015313</ArticleId><ArticleId IdType="pubmed">33795830</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons T., Banks S., Bae C., Gelber J., Alahmadi H., Tichauer M. COVID-19-associated acute disseminated encephalomyelitis (ADEM) J. Neurol. 2020;267:2799&#x2013;2802. doi: 10.1007/s00415-020-09951-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09951-9</ArticleId><ArticleId IdType="pmc">PMC7260459</ArticleId><ArticleId IdType="pubmed">32474657</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez C.A. Looking ahead: the risk of neurologic complications due to COVID-19. Neurol. Clin. Pract. 2020;10 doi: 10.1212/cpj.0000000000000836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/cpj.0000000000000836</ArticleId><ArticleId IdType="pmc">PMC7508336</ArticleId><ArticleId IdType="pubmed">32983618</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., Jbabdi S., Taschler B., Keating P., Winkler A.M., Collins R., Matthews P.M., Allen N., Miller K.L., Nichols T.E., Smith S.M. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders R.D., Maze M. Contribution of sedative-hypnotic agents to delirium via modulation of the sleep pathway. Can. J. Anesthesia J. Can. D'anesth&#xe9;sie. 2011;58:149&#x2013;156. doi: 10.1007/s12630-010-9421-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-010-9421-2</ArticleId><ArticleId IdType="pmc">PMC3033507</ArticleId><ArticleId IdType="pubmed">21170622</ArticleId></ArticleIdList></Reference><Reference><Citation>Egberts A., Moreno-Gonzalez R., Alan H., Ziere G., Mattace-Raso F.U.S. Anticholinergic drug burden and delirium: a systematic review. J. Am. Med. Dir Assoc. 2021;22:65&#x2013;73. doi: 10.1016/j.jamda.2020.04.019. e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.04.019</ArticleId><ArticleId IdType="pubmed">32703688</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazot P.L., Johnston L., Mcauley E., Bonner S. histamine and delirium: current opinion. Front. Pharmacol. 2019;10:299. doi: 10.3389/fphar.2019.00299.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00299</ArticleId><ArticleId IdType="pmc">PMC6467166</ArticleId><ArticleId IdType="pubmed">31024298</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayah W., Berkane I., Guermache I., Sabri M., Lakhal F.Z., Yasmine S.R., Djidjeli A., Lamara L.M., Merah F., Belaid G., Berkani L., Lazli N.Z., Kheddouci L., Kadi A., Ouali M., Khellafi R., Mekideche D., Kheliouen A., Hamidi R.M., Ayoub S., Raaf N.B., Derrar F., Gharnaout M., Allam I., Djidjik R. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Cytokine. 2021;141 doi: 10.1016/j.cyto.2021.155428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155428</ArticleId><ArticleId IdType="pmc">PMC7834734</ArticleId><ArticleId IdType="pubmed">33550165</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato U., Muccioli L., Cani I., Janigro D., Zinzani P.L., Guarino M., Cortelli P., Bisulli F. Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy. Ann. Clin. Transl. Neur. 2021;8:968&#x2013;979. doi: 10.1002/acn3.51348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51348</ArticleId><ArticleId IdType="pmc">PMC8045903</ArticleId><ArticleId IdType="pubmed">33780166</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsini A., Merrick B., Edgeworth J., Mandal G., Srivastava D.P., Vernon A.C., Nebbia G., Thuret S., Pariante C.M. Neurogenesis is disrupted in human hippocampal progenitor cells upon exposure to serum samples from hospitalized COVID-19 patients with neurological symptoms. Mol. Psychiatr. 2022;27:5049&#x2013;5061. doi: 10.1038/s41380-022-01741-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01741-1</ArticleId><ArticleId IdType="pmc">PMC9763123</ArticleId><ArticleId IdType="pubmed">36195636</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter M.M., Martins T.A., Kulsvehagen L., P&#xf6;ssnecker E., Duchemin W., Hogan S., Sanabria-Diaz G., M&#xfc;ller J., Chiappini A., Rychen J., Eberhard N., Guzman R., Mariani L., Melie-Garcia L., Keller E., Jelcic I., Pargger H., Siegemund M., Kuhle J., Oechtering J., Eich C., Tzankov A., Matter M.S., Uzun S., Yaldizli &#xd6;., Lieb J.M., Psychogios M.-.N., Leuzinger K., Hirsch H.H., Granziera C., Pr&#xf6;bstel A.-.K., Hutter G. Severe neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat. Commun. 2022;13:6777. doi: 10.1038/s41467-022-34068-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., Liu M.Q., Chen Y., Shen X.R., Wang X., Zheng X.S., Zhao K., Chen Q.J., Deng F., Liu L.L., Yan B., Zhan F.X., Wang Y.Y., Xiao G.F., Shi Z.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7. Erratum in: Nature. 588 (2020) E6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-converting enzyme 2: sARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Henjum K., Quist-Paulsen E., Zetterberg H., Blennow K., Nilsson L.N.G., Watne L.O. CSF sTREM2 in delirium&#x2014;relation to Alzheimer's disease CSF biomarkers A&#x3b2;42, t-tau and p-tau. J. Neuroinflamm. 2018;15:304. doi: 10.1186/s12974-018-1331-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1331-1</ArticleId><ArticleId IdType="pmc">PMC6215363</ArticleId><ArticleId IdType="pubmed">30390679</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong T.G., Inouye S.K. The inter-relationship between delirium and dementia: the importance of delirium prevention. Nat. Rev. Neurol. 2022;18:579&#x2013;596. doi: 10.1038/s41582-022-00698-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-022-00698-7</ArticleId><ArticleId IdType="pmc">PMC9415264</ArticleId><ArticleId IdType="pubmed">36028563</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Valnet R., Favre E., Bernini A., Oddo M., Chiche J.-.D., Pasquier R.A.D., Rossetti A.O., on behalf of the C.-N.-I.S. Group Delirium in adults with COVID-19&#x2013;related acute respiratory distress syndrome: comparison with other etiologies. Neurology. 2022;99:e2326&#x2013;e2335. doi: 10.1212/wnl.0000000000201162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000201162</ArticleId><ArticleId IdType="pmc">PMC9695422</ArticleId><ArticleId IdType="pubmed">36376086</ArticleId></ArticleIdList></Reference><Reference><Citation>Naughton S.X., Raval U., Pasinetti G.M. Potential novel role of COVID-19 in Alzheimer's disease and preventative mitigation strategies. J. Alzheimer's Dis. 2020;76:21&#x2013;25. doi: 10.3233/jad-200537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-200537</ArticleId><ArticleId IdType="pmc">PMC8057202</ArticleId><ArticleId IdType="pubmed">32538855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz G.G., Vel&#xe1;zquez-Brizuela I.E., Ortiz-Vel&#xe1;zquez G.E., Ocampo-Alfaro M.J., Salazar-Flores J., Delgado-Lara D.L.C., Torres-Sanchez E.D. Alzheimer's disease and SARS-CoV-2: pathophysiological analysis and social context. Brain Sci. 2022;12:1405. doi: 10.3390/brainsci12101405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12101405</ArticleId><ArticleId IdType="pmc">PMC9599687</ArticleId><ArticleId IdType="pubmed">36291338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.A., Islam K., Rahman S., Alamin M. Neurobiochemical cross-talk between COVID-19 and Alzheimer's disease. Mol. Neurobiol. 2021;58:1017&#x2013;1023. doi: 10.1007/s12035-020-02177-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02177-w</ArticleId><ArticleId IdType="pmc">PMC7571527</ArticleId><ArticleId IdType="pubmed">33078369</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H., Cummings J., Blennow K., Gao P., Jack C.R., Vergallo A. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat. Rev. Neurol. 2021;17:580&#x2013;589. doi: 10.1038/s41582-021-00520-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-021-00520-w</ArticleId><ArticleId IdType="pubmed">34239130</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S., Sittenfeld L., Dridi H., Liu Y., Liu X., Marks A.R. Alzheimer's-like signaling in brains of COVID-19 patients. Alzheimer's Dementia. 2022;18:955&#x2013;965. doi: 10.1002/alz.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji S., Minami S., Hashimoto R., Konishi Y., Suzuki T., Kondo T., Sasai M., Torii S., Ono C., Shichinohe S., Sato S., Wakita M., Okumura S., Nakano S., Matsudaira T., Matsumoto T., Kawamoto S., Yamamoto M., Watanabe T., Matsuura Y., Takayama K., Kobayashi T., Okamoto T., Hara E. SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response. Nat. Aging. 2022;2:115&#x2013;124. doi: 10.1038/s43587-022-00170-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00170-7</ArticleId><ArticleId IdType="pmc">PMC10154207</ArticleId><ArticleId IdType="pubmed">37117754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Zhou Z. COVID-19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ann. Clin. Transl. Neur. 2022;9:1953&#x2013;1961. doi: 10.1002/acn3.51688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51688</ArticleId><ArticleId IdType="pmc">PMC9735364</ArticleId><ArticleId IdType="pubmed">36321943</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuno T., Itoshima H., Shin J., Morishita T., Kunisawa S., Imanaka Y. Physical restraint of dementia patients in acute care hospitals during the COVID-19 pandemic: a cohort analysis in Japan. PLoS ONE. 2021;16 doi: 10.1371/journal.pone.0260446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260446</ArticleId><ArticleId IdType="pmc">PMC8608313</ArticleId><ArticleId IdType="pubmed">34807945</ArticleId></ArticleIdList></Reference><Reference><Citation>Funayama M., Takata T. Psychiatric inpatients subjected to physical restraint have a higher risk of deep vein thrombosis and aspiration pneumonia. Gen. Hosp. Psychiat. 2020;62:1&#x2013;5. doi: 10.1016/j.genhosppsych.2019.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2019.11.003</ArticleId><ArticleId IdType="pubmed">31734627</ArticleId></ArticleIdList></Reference><Reference><Citation>Baller E.B., Hogan C.S., Fusunyan M.A., Ivkovic A., Luccarelli J.W., Madva E., Nisavic M., Praschan N., Quijije N.V., Beach S.R., Smith F.A. Neurocovid: pharmacological recommendations for delirium associated with COVID-19. Psychosomatics. 2020;61:585&#x2013;596. doi: 10.1016/j.psym.2020.05.013. 4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psym.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7240270</ArticleId><ArticleId IdType="pubmed">32828569</ArticleId></ArticleIdList></Reference><Reference><Citation>The National Institute for Health and Care Excellence: COVID-19 rapid guideline: managing COVID-19 NICE guideline [NG191]. https://www.nice.org.uk/guidance/ng191. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">34181371</ArticleId></ArticleIdList></Reference><Reference><Citation>European Society for Medical Oncology: Cancer patient management during the COVID-19 pandemic: palliative care prioritisation during the COVID-19 crisis. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic/palliative-care-in-the-covid-19-era. 2021.</Citation></Reference><Reference><Citation>di Giacomo E., Bellelli G., Peschi G., Scarpetta S., Colmegna F., Girolamo G., Clerici M. Management of older people during the COVID-19 outbreak: recommendations from an Italian experience. Int. J. Geriat. Psychiatry. 2020;35:803&#x2013;805. doi: 10.1002/gps.5318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5318</ArticleId><ArticleId IdType="pubmed">32363628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta K., Kishi Y., Wada K., Takeuchi T., Odawara T., Usui C., Nakamura H., D.-J. Group Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. Jama Psychiat. 2014;71:397&#x2013;403. doi: 10.1001/jamapsychiatry.2013.3320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2013.3320</ArticleId><ArticleId IdType="pubmed">24554232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta K., Kishi Y., Wada K., Takeuchi T., Ito S., Kurata A., Murakami K., Sugita M., Usui C., Nakamura H., D.-J. Group Preventive effects of suvorexant on delirium: a randomized placebo-controlled trial. J. Clin. Psychiatry. 2017;78:e970&#x2013;e979. doi: 10.4088/jcp.16m11194.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/jcp.16m11194</ArticleId><ArticleId IdType="pubmed">28767209</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>